News
Montara Therapeutics awarded $3.3 million non-dilutive MJFF grant to develop BrainOnly™ Parkinson's therapy targeting LRRK2, a genetically validated target with major drug development challenges. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback